| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |